Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandip Basu

Showing results (351-360 of 520) with videos related to

Pageof 52
Sort By:
Molecular Imaging and Biology|December 8, 2010
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessmentSandip Basu, Babak Saboury, Drew A Torigian, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 15, 2021
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [<sup>177</sup>Lu]Lu-DOTA-TATE and the Trend with Multiple CyclesKamaldeep, Sarvesh Loharkar, Tapas Das, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2007
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancerTevfik F Cermik, Ayse Mavi, Sandip Basu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2009
FDG PET/CT in carcinoma of unknown primaryThomas C Kwee, Sandip Basu, Gang Cheng, et al.
Clinical Nuclear Medicine|March 17, 2025
Serendipitous Discovery and Characterization of Two Different Pathologies on 68Ga-DOTATATE and 68Ga-Exendin PET/CT in a Patient With Hyperinsulinemic Hypoglycemia Leading to Diagnosis of MEN-1Rucha Barapatre, Priyanka Verma, Anurag R Lila, et al.
Cancers|July 27, 2024
Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive ReviewNivedita Chakrabarty, Abhishek Mahajan, Sandip Basu, et al.
Clinical Nuclear Medicine|June 11, 2024
Multifocal Burkholderia cepacia Infection in Postrenal Transplantation Fever : Role of 18 F-FDG PET/CT in Treatment OptimizationSunita Nitin Sonavane, Tukaram Jamale, Sreyasi Bose, et al.
Nuclear Medicine Communications|February 5, 2024
Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68 Ga-PSMA-11 positron-emission tomography/computed tomography imaging for potential theranosticsRahul V Parghane, Tejal Suralkar, Dilip Nikam, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 2, 2023
What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of <sup>18</sup>F-FDG PET/CT in monitoring response to treatmentSarvesh Loharkar, Sunita N Sonavane, Hetan Shah, et al.
PET Clinics|June 21, 2016
PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine TumorsSandip Basu, Rohit Ranade, Vikas Ostwal, et al.
Pageof 52

Showing results (351-360 of 520) with videos related to

Sort By:
Pageof 52
Molecular Imaging and Biology|December 8, 2010
Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessmentSandip Basu, Babak Saboury, Drew A Torigian, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 15, 2021
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[<sup>177</sup>Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [<sup>177</sup>Lu]Lu-DOTA-TATE and the Trend with Multiple CyclesKamaldeep, Sarvesh Loharkar, Tapas Das, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 25, 2007
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancerTevfik F Cermik, Ayse Mavi, Sandip Basu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 3, 2009
FDG PET/CT in carcinoma of unknown primaryThomas C Kwee, Sandip Basu, Gang Cheng, et al.
Clinical Nuclear Medicine|March 17, 2025
Serendipitous Discovery and Characterization of Two Different Pathologies on 68Ga-DOTATATE and 68Ga-Exendin PET/CT in a Patient With Hyperinsulinemic Hypoglycemia Leading to Diagnosis of MEN-1Rucha Barapatre, Priyanka Verma, Anurag R Lila, et al.
Cancers|July 27, 2024
Imaging Recommendations for Diagnosis and Management of Primary Parathyroid Pathologies: A Comprehensive ReviewNivedita Chakrabarty, Abhishek Mahajan, Sandip Basu, et al.
Clinical Nuclear Medicine|June 11, 2024
Multifocal Burkholderia cepacia Infection in Postrenal Transplantation Fever : Role of 18 F-FDG PET/CT in Treatment OptimizationSunita Nitin Sonavane, Tukaram Jamale, Sreyasi Bose, et al.
Nuclear Medicine Communications|February 5, 2024
Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68 Ga-PSMA-11 positron-emission tomography/computed tomography imaging for potential theranosticsRahul V Parghane, Tejal Suralkar, Dilip Nikam, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 2, 2023
What is this image? 2023 Image 3 results: Cardiac tuberculosis presenting as cardiac mass: role of <sup>18</sup>F-FDG PET/CT in monitoring response to treatmentSarvesh Loharkar, Sunita N Sonavane, Hetan Shah, et al.
PET Clinics|June 21, 2016
PET-Based Molecular Imaging in Designing Personalized Management Strategy in Gastroenteropancreatic Neuroendocrine TumorsSandip Basu, Rohit Ranade, Vikas Ostwal, et al.
Pageof 52